<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00477776</url>
  </required_header>
  <id_info>
    <org_study_id>NHG SIG 06022</org_study_id>
    <nct_id>NCT00477776</nct_id>
  </id_info>
  <brief_title>Maxolon to Improve Breastmilk Supply in Diabetic Women: a Randomised Controlled Trial</brief_title>
  <acronym>Maxalon</acronym>
  <official_title>Metoclopramide to Improve Lactogenesis II in Diabetic Women: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of Western Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early use of oral maxalon can hasten and improve the establishment of breastfeeding in
      diabetic mothers after preterm and term deliveries.

      Maxolon promotes breastfeeding by working on the central nervous system which increases the
      milk producing hormone, prolactin which in turn helps to increase the milk supply for
      breastfeeding. Successful early breastfeeding establishment is important for continued
      breastfeeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to determine the breastfeeding initiation and duration rate of a cohort of
      pregnant women with gestational diabetes(diet-controlled) and insulin dependent and
      pre-existing diabetes, assess the impact of a post natally administered galactogogue,
      metoclopramide on the milk volume production and timing of lactogenesis II in diabetic women
      on diet control and insulin and determine the prolactin response to lactation among diabetic
      women on diet control and insulin.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>a.successful initiation of lactation as determined by lactogenesis II markers, maternal perception and timing c.timing of successful establishment of lactogenesis II</measure>
    <time_frame>within the first two weeks postpartum</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>amount of breastmilk determined by testweighing and expressed milk volumes, weight change on day 7 and breastfeeding status up to 6 months</measure>
    <time_frame>within 6 months postpartum</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Breastfeeding</condition>
  <arm_group>
    <arm_group_label>a</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mother with diet-controlled diabetes receive Metoclopramide 10 mg 3 times a day for the first 7 days, and 2 times a day for day 8 to 10, and once a day from day 11 to day 12</description>
  </arm_group>
  <arm_group>
    <arm_group_label>b</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 10 mg 3 times a day for 7 days, 2 times a day from day 8 to day 10, and once a day for day 11 to 12</description>
  </arm_group>
  <arm_group>
    <arm_group_label>c</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Metoclopramide 10 mg 3 times a day for 7 days, 2 times a day from day 8 to day 10, and once a day from day 11 to 12</description>
  </arm_group>
  <arm_group>
    <arm_group_label>d</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 10 mg 3 times a day for 7 days, 2 times a day for day 8 to 10; and once a day from day 11 to 12</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metoclopramide (Maxolon)</intervention_name>
    <description>Metoclopramide 10 mg 3 times a day for 7 days, 2 times a day from day 8 to day 10, once a day for day 11 and 12</description>
    <arm_group_label>a</arm_group_label>
    <arm_group_label>c</arm_group_label>
    <other_name>Maxalon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo 10 mg 3 times a day for 7 days, 2 times a day from day 8 to 10, once a day from day 11 to 12</description>
    <arm_group_label>b</arm_group_label>
    <arm_group_label>d</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All pregnant women with pregestational or gestational diabetes under diet or insulin
             control

        Exclusion Criteria:

          -  Patient who have epilepsy or on anti-seizure medications,

          -  Patients who have a history of significant depression or are on antidepressant drugs

          -  Patients who have pheochromocytoma or uncontrolled hypertension

          -  Patients who have intestinal bleeding or obstruction

          -  Patient with known allergy or prior reaction to metoclopramide

          -  Patient with HIV infection

          -  Current pregnancy complicated by fetal congenital anomalies and multiple fetuses
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chong Y S, MBBS,MRACOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital and National University of Singapore</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Citra Mattar, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital, Singapore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>Cregan MD, De Mello TR, Kershaw D, McDougall K, Hartmann PE. Initiation of lactation in women after preterm delivery. Acta Obstet Gynecol Scand. 2002 Sep;81(9):870-7.</citation>
    <PMID>12225305</PMID>
  </reference>
  <reference>
    <citation>Hartmann PE, Cregan MD, Mitoulas LR. Maternal modulation of specific and non-specific immune components of colostrum and mature milk. Adv Nutr Res. 2001;10:365-87. Review.</citation>
    <PMID>11795051</PMID>
  </reference>
  <reference>
    <citation>Hartmann P, Cregan M. Lactogenesis and the effects of insulin-dependent diabetes mellitus and prematurity. J Nutr. 2001 Nov;131(11):3016S-20S. Review.</citation>
    <PMID>11694639</PMID>
  </reference>
  <reference>
    <citation>Hansen WF, McAndrew S, Harris K, Zimmerman MB. Metoclopramide effect on breastfeeding the preterm infant: a randomized trial. Obstet Gynecol. 2005 Feb;105(2):383-9.</citation>
    <PMID>15684169</PMID>
  </reference>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2007</study_first_submitted>
  <study_first_submitted_qc>May 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2007</study_first_posted>
  <last_update_submitted>September 18, 2009</last_update_submitted>
  <last_update_submitted_qc>September 18, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Professor Chong Yap Seng</name_title>
    <organization>National University Hospital</organization>
  </responsible_party>
  <keyword>Beginning of breastfeeding</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metoclopramide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

